Mark Krueger, who ran his own healthcare constitutency relations consulting firm for 23 years before selling it in 2018, has joined APCO Worldwide as executive director in its New York office.
Working for biotech, pharmaceutical, medical device and diagnostics clients, Mark Krueger & Assocs. is noted for creating/implementing ways to speed drug discovery, quicken regulatiory approval and demonstrate its value to lead to appropriate pricing, access and reimbursement.
Brad Staples, APCO CEO, praised Krueger as a "trusted partner" to patient, consumer groups, NGOs and professional societies. "Mark has a proven track record of creating respectful partnerships focused on interests shared between these groups, industry, government and other members of the community,” he said.
Alexandra Lazorchak leads APCO's North American health practice and co-chairs the global health unit with James Tyrrell.